NCT04840043

Brief Summary

Depression appears to be resistant to the available pharmacological treatments. Autonomic responses accompanied by any psychological stress are sympathetic nervous system (SNS) and neuroendocrine responses are formed by hypothalamus-pituitary-adrenal (HPA) axis. The purpose of this study is; assessment of effectiveness of osteopathic approach on sympathetic nervous system and HPA axis in adolescents with depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2018

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
Last Updated

April 9, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

April 4, 2021

Last Update Submit

April 7, 2021

Conditions

Keywords

DepressionSympathetic nervous systemCortisol

Outcome Measures

Primary Outcomes (8)

  • The Beck Depression Inventory (BDI)

    The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.

    Before intervention

  • The State-Trait Anxiety Inventory (STAI) Form - 1

    The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety. It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It also is often used in research as an indicator of caregiver distress.

    Before intervention

  • Change from Baseline The State-Trait Anxiety Inventory (STAI) Form - 2 at 20 minutes

    The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety. It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It also is often used in research as an indicator of caregiver distress.

    Before intervention, immediately after the intervention, 20 minutes after the intervention

  • Change from Baseline Heart rate and blood pressure measurements at 20 minutes

    Heart rate (beats per minute) and blood pressure (mm/Hg) were measured with automatic blood pressure monitor (the Microlife BP 3BT0-A). It is a clinically validated and 1-star automatic blood pressure monitor

    Before intervention, immediately after the intervention, 20 minutes after the intervention

  • Change from Baseline Salivary Biomarkers at 20 minutes

    Salivary a-amylase and cortisol levels were measured for each sample. These biomarkers were analysed Enzyme-Linked Immunosorbent Assay.

    Before intervention, immediately after the intervention, 20 second after the intervention

  • Demographic data

    Sex; male or female

    Before intervention

  • Demographic data

    Age; years

    Before intervention

  • Demographic data

    Height (m); weight (kg); body mass index (kg/m2)

    Before intervention

Study Arms (2)

Osteopathy Group

EXPERIMENTAL

Stimulation on the sympathetic truncus and prevertebral ganglia

Other: Osteopathic sympathic harmonization

Control Group

SHAM COMPARATOR

Stimulation on similar areas with lighter touch and shorter duration

Other: Sham intervention

Interventions

Treatments that harmonize at the sympathetic nerves or plexus, e.g., sympathetic trunk stimulation by means of the rib-raise technique or stimulation of the prevertebral ganglia.

Osteopathy Group

Different location, size and time of the rib-raise technique or stimulation of the prevertebral ganglia.

Control Group

Eligibility Criteria

Age15 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • To be diagnosed with clinical depression by a psychiatrist according to The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria
  • Volunteering to participate in the study

You may not qualify if:

  • Fever over 38.5
  • Acute injury or infection
  • Rib fracture
  • Cardiac arrhythmia
  • Using drugs that affect cortisol levels (oral contraceptives, hormonal drugs, antidepressants, antipsychotics etc.)
  • Being pregnant, premenstrual or in the menstrual period for female participants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sivas Cumhuriyet University

Sivas, 58140, Turkey (Türkiye)

Location

Related Publications (2)

  • Henderson AT, Fisher JF, Blair J, Shea C, Li TS, Bridges KG. Effects of rib raising on the autonomic nervous system: a pilot study using noninvasive biomarkers. J Am Osteopath Assoc. 2010 Jun;110(6):324-30.

    PMID: 20606239BACKGROUND
  • Pala OO, Citaker S, Guney E, Sepici A, Guveli GM, Arslan B, Guru M. Effectiveness of osteopathic manipulative applications on hypothalamic-pituitary-adrenal (HPA) axis in youth with major depressive disorder: a randomized double-blind, placebo-controlled trial. J Osteopath Med. 2024 Feb 29;124(6):267-275. doi: 10.1515/jom-2023-0056. eCollection 2024 Jun 1.

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Omer Osman PALA, PhD

    Cumhuriyet University, Faculty of Health Sciences, Physiotherapy and Rehabilitation

    STUDY DIRECTOR
  • Seyit CITAKER, Prof

    Gazi University, Faculty of Health Sciences, Physiotherapy and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • Esra GUNEY, Assoc. Prof

    Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry

    PRINCIPAL INVESTIGATOR
  • Aylin SEPICI DINCEL, Prof

    Gazi University, Faculty of Medicine, Medical Biochemistry

    PRINCIPAL INVESTIGATOR
  • Güner Melike GUVELI, MD

    Gazi University, Faculty of Medicine, Child and Adolescent Psychiatry

    PRINCIPAL INVESTIGATOR
  • Burak ARSLAN, MD

    Gazi University, Faculty of Medicine, Medical Biochemistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double-blind trial
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A double-blind, placebo-controlled, randomized study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 4, 2021

First Posted

April 9, 2021

Study Start

October 11, 2017

Primary Completion

March 23, 2018

Study Completion

June 5, 2018

Last Updated

April 9, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR, ANALYTIC CODE
Time Frame
January 1, 2022

Locations